Medical Condition News

RSS

Single-dose genetic medicine halts the progression of ALS and frontotemporal dementia in mice

Neuroscientists at Macquarie University in Australia have developed a single-dose genetic medicine that has been proven to halt the progression of both ALS and frontotemporal dementia (FTD) in mice – and may even offer the potential to reverse some of the effects of the fatal diseases.

19 Feb 2024

Rising medication costs pose barrier to diabetes treatment, study finds

Actively managing diabetes is crucial to preventing long-term health complications, but rising costs are creating barriers to treatment.

19 Feb 2024

Exercise unleashes anti-inflammatory power against autoimmune diseases

The impact of exercise training on reducing inflammation in adolescents and adults with autoimmune diseases.

19 Feb 2024

Understanding the impact of spring allergies on different body systems

If you suffer from spring allergies, you already know you tend to feel miserable once pollen season descends.

19 Feb 2024

Reversing time: Hyaluronic acid injections offer lasting improvement in aging skin

How deleterious changes could be reversed by injecting cross-linked hyaluronic acid (CL-HA).

19 Feb 2024

Healthy lifestyles linked to specific metabolic markers, large study finds

Researchers identify metabolomic markers linked to healthy lifestyles in a large study, showing a connection between lipid metabolism and reduced mortality risks.

18 Feb 2024

Long COVID prevalence varies widely across US states, CDC study finds

The CDC's nationwide study reveals varying long COVID prevalence across the USA, from 1.9% in the Virgin Islands to 10.6% in West Virginia, underscoring the need for targeted public health strategies.

18 Feb 2024

Deep learning shines a new light on Parkinson's detection through the eye

Study demonstrates the potential of deep learning algorithms to predict Parkinson's disease (PD) through retinal fundus imaging, offering a non-invasive, early diagnostic tool.

18 Feb 2024

Wastewater clues could revolutionize Alzheimer's detection

Review explores the potential of wastewater-based epidemiology (WBE) for diagnosing Alzheimer's disease (AD) through biomarkers in biofluids, offering a non-invasive, cost-effective approach to early detection and large-scale monitoring.

18 Feb 2024

New study pinpoints key markers for Long COVID diagnosis

Study identifies elevated serologic responses and memory CD8+ T cell clonal expansion as key markers of Long COVID, offering insights into its pathology and potential diagnostic approaches.

18 Feb 2024

Pilates lowers blood pressure in hypertensive patients, study finds

Pilates training programs are deemed safe and effective for managing blood pressure in hypertensive patients, offering a viable rehabilitation option alongside traditional treatments.

18 Feb 2024

Researchers introduce a pioneering approach to combat neurodegenerative diseases

Researchers led by Northwestern University and the University of Wisconsin-Madison have introduced a pioneering approach aimed at combating neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and Amyotrophic lateral sclerosis (ALS).

16 Feb 2024

Optimizing chemotherapy for older adults with advanced cancer

Standard chemotherapy regimens, which are mostly based on testing in relatively young and healthy patients, may do more harm to older adults with cancer who often struggle with other health issues.

16 Feb 2024

Evaluating a machine learning tool for predicting hospital-acquired acute kidney injury

Hospital-acquired acute kidney injury (HA-AKI) is a common complication in hospitalized patients that can lead to chronic kidney disease and is associated with longer hospital stays, higher health care costs and increased mortality.

16 Feb 2024

Lockdown delays in melanoma diagnosis cost Europe £6bn and thousands of lives

Delays in diagnosing melanoma due to Covid-19 lockdown may have contributed to over 100,000 years of life lost across Europe and over £6bn in costs, mainly indirectly due to loss of productivity, finds a new study led by UCL and University Hospital of Basel researchers.

16 Feb 2024

Innovative immunotherapy targets rare melanoma subtypes

Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have built and demonstrated the potential efficacy of a new chimeric antigen receptor (CAR) T-cell-based immunotherapy specifically designed to treat patients with cutaneous and rare subtypes of melanoma.

16 Feb 2024